A multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin compared with standard therapy for the treatment of transverse myelitis in adults and children (STRIVE). (2017)
Attributed to:
MRC Centre for Neuropsychiatric Genetics and Genomics
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3310/hta21310
PubMed Identifier: 28639937
Publication URI: http://europepmc.org/abstract/MED/28639937
Type: Journal Article/Review
Volume: 21
Parent Publication: Health technology assessment (Winchester, England)
Issue: 31
ISSN: 1366-5278